JP2019504103A5 - - Google Patents

Download PDF

Info

Publication number
JP2019504103A5
JP2019504103A5 JP2018540797A JP2018540797A JP2019504103A5 JP 2019504103 A5 JP2019504103 A5 JP 2019504103A5 JP 2018540797 A JP2018540797 A JP 2018540797A JP 2018540797 A JP2018540797 A JP 2018540797A JP 2019504103 A5 JP2019504103 A5 JP 2019504103A5
Authority
JP
Japan
Prior art keywords
formula
crystalline form
compound
crystalline
ray powder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018540797A
Other languages
English (en)
Japanese (ja)
Other versions
JP6877450B2 (ja
JP2019504103A (ja
Filing date
Publication date
Priority claimed from CN201610081899.3A external-priority patent/CN107043377A/zh
Application filed filed Critical
Publication of JP2019504103A publication Critical patent/JP2019504103A/ja
Publication of JP2019504103A5 publication Critical patent/JP2019504103A5/ja
Application granted granted Critical
Publication of JP6877450B2 publication Critical patent/JP6877450B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018540797A 2016-02-05 2017-02-04 Tlr7アゴニストのトリフルオロ酢酸塩及びその結晶形b、調製方法、並びに使用 Active JP6877450B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201610081899.3 2016-02-05
CN201610081899.3A CN107043377A (zh) 2016-02-05 2016-02-05 一种tlr7激动剂的三氟乙酸盐、晶型b及其制备方法、药物组合物和用途
PCT/CN2017/072894 WO2017133687A1 (zh) 2016-02-05 2017-02-04 一种tlr7激动剂的三氟乙酸盐、晶型b、制备方法和用途

Publications (3)

Publication Number Publication Date
JP2019504103A JP2019504103A (ja) 2019-02-14
JP2019504103A5 true JP2019504103A5 (OSRAM) 2020-02-27
JP6877450B2 JP6877450B2 (ja) 2021-05-26

Family

ID=59500539

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018540797A Active JP6877450B2 (ja) 2016-02-05 2017-02-04 Tlr7アゴニストのトリフルオロ酢酸塩及びその結晶形b、調製方法、並びに使用

Country Status (23)

Country Link
US (1) US10683296B2 (OSRAM)
EP (1) EP3412674B1 (OSRAM)
JP (1) JP6877450B2 (OSRAM)
KR (1) KR102393281B1 (OSRAM)
CN (2) CN107043377A (OSRAM)
AR (1) AR107550A1 (OSRAM)
AU (1) AU2017214135B2 (OSRAM)
CA (1) CA3013521C (OSRAM)
CL (1) CL2018002101A1 (OSRAM)
DK (1) DK3412674T3 (OSRAM)
EA (1) EA037048B1 (OSRAM)
ES (1) ES2834304T3 (OSRAM)
HU (1) HUE052210T2 (OSRAM)
IL (1) IL260981B (OSRAM)
MX (1) MX374300B (OSRAM)
MY (1) MY198137A (OSRAM)
NZ (1) NZ745023A (OSRAM)
PH (1) PH12018501641B1 (OSRAM)
SG (1) SG11201806688QA (OSRAM)
TW (1) TWI778952B (OSRAM)
UA (1) UA121276C2 (OSRAM)
WO (1) WO2017133687A1 (OSRAM)
ZA (1) ZA201805240B (OSRAM)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA201891620A1 (ru) 2016-02-05 2019-02-28 Денали Терапьютикс Инк. Ингибиторы взаимодействующей с рецептором протеинкиназы 1
CN107043378A (zh) * 2016-02-05 2017-08-15 正大天晴药业集团股份有限公司 一种吡咯并[3,2-d]嘧啶类化合物的制备方法及其中间体
CN107043380A (zh) * 2016-02-05 2017-08-15 正大天晴药业集团股份有限公司 一种tlr7激动剂的马来酸盐、其晶型c、晶型d、晶型e、制备方法和用途
JP7385602B2 (ja) * 2018-05-25 2023-11-22 チア タイ ティエンチン ファーマシューティカル グループ カンパニー リミテッド 肺癌を治療するためのtlr7アゴニストおよびその医薬の組み合わせ
MX2021009496A (es) 2019-02-08 2021-09-08 Progeneer Inc Complejo de colesterol-agonista del receptor 7 u 8 tipo larga distancia, y uso del mismo.
WO2021177679A1 (ko) 2020-03-02 2021-09-10 성균관대학교산학협력단 병원균 외벽 성분 기반 생병원체 모방 나노 입자 및 그 제조 방법
EP4194006A4 (en) 2020-08-04 2024-12-04 Progeneer Inc. mRNA VACCINE WITH AN ADJUVANT CAPABLE OF KINETIC CONTROL
JP2023536954A (ja) 2020-08-04 2023-08-30 プロジェニア インコーポレイテッド 活性化部位が一時的に不活性化したトール様受容体7または8作用薬と機能性薬物の結合体およびその用途
US20230355750A1 (en) 2020-08-04 2023-11-09 Progeneer Inc. Kinetically acting adjuvant ensemble
MX2024008648A (es) 2022-01-12 2024-09-23 Denali Therapeutics Inc Formas cristalinas de (s)-5-bencil-n-(5-metil-4-oxo-2,3,4,5-tetrah idropirido [3,2- b][1,4]oxacepin-3-il)-4h-1,2,4-triazol-3-carboxam ida.
CN119431359A (zh) * 2023-07-28 2025-02-14 苏州申拓医药科技有限公司 一种tlr7/8激动剂的可药用盐、晶型及其制备方法、药物组合物和用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3376479B2 (ja) * 1991-08-12 2003-02-10 武田薬品工業株式会社 縮合ピリミジン誘導体、その製造法および用途
NZ593110A (en) 2008-12-09 2013-06-28 Gilead Sciences Inc pteridinone derivatives as MODULATORS OF TOLL-LIKE RECEPTORS
US9139590B2 (en) 2011-02-04 2015-09-22 Duquesne University Of The Holy Spirit Bicyclic and tricyclic pyrimidine tyrosine kinase inhibitors with antitubulin activity and methods of treating a patient
WO2013103967A1 (en) 2012-01-05 2013-07-11 Northeastern University Allosteric modulators of cb1 cannabinoid receptors
MX365114B (es) * 2012-10-10 2019-05-23 Janssen Sciences Ireland Uc Derivados pirrolo[3,2-d]pirimidinicos para el tratamiento de infecciones viricas y otras enfermedades.
RU2643371C2 (ru) * 2012-11-20 2018-02-01 ГЛАКСОСМИТКЛАЙН ЭлЭлСи Новые соединения
PL3137470T3 (pl) * 2014-05-01 2021-10-11 Novartis Ag Związki i kompozycje jako agonisty receptora toll-like 7
ES2908150T3 (es) * 2014-05-01 2022-04-27 Novartis Ag Compuestos y composiciones como agonistas del receptor de tipo Toll 7
PL3190113T3 (pl) * 2014-08-15 2021-10-25 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Związki pirolopirymidynowe stosowane jako agonista TLR7
CN105367576A (zh) * 2014-08-15 2016-03-02 正大天晴药业集团股份有限公司 作为tlr7激动剂的吡咯并嘧啶化合物
CN105732635A (zh) * 2014-12-29 2016-07-06 南京明德新药研发股份有限公司 一类Toll样受体7激动剂

Similar Documents

Publication Publication Date Title
JP2019504103A5 (OSRAM)
JP2019505533A5 (OSRAM)
JP2019505532A5 (OSRAM)
JP2014501282A5 (OSRAM)
JP2021530565A5 (OSRAM)
JP2013049690A5 (OSRAM)
JP2017505329A5 (OSRAM)
JP6483674B2 (ja) 5−ブロモ−2−(α−ヒドロキシペンチル)安息香酸ナトリウム塩の複数の異なる結晶型及びそれらの調製方法
JP2005503386A5 (OSRAM)
JP2015522644A5 (OSRAM)
JP2014524442A5 (OSRAM)
JP2013516473A5 (OSRAM)
HRP20201644T1 (hr) Kristalni oblik 2-butoksi-7-(4-(pirolidin-1-ilmetil)benzil)-5h-pirolo [3,2-d]pirimidin-4-amina kao agonist tlr7, postupak njegove proizvodnje i njegova uporaba
JP2016510323A5 (OSRAM)
JP2009537603A (ja) 5−アミノ−3−(2’,3’−ジ−O−アセチル−ベータ−D−リボフラノシル)−3H−チアゾロ[4,5−d]ピリミジン−2−オンのマレイン酸塩のA型及びB型結晶形
RU2018145948A (ru) Кристалл пирролопиримидина для получения jak-ингибитора
JP2020517611A5 (OSRAM)
JP6779972B2 (ja) 呼吸器合胞体ウイルス(rsv)感染症の処置のためのn−[(3−アミノ−3−オキセタニル)メチル]−2−(2,3−ジヒドロ−1,1−ジオキシド−1,4−ベンゾチアゼピン−4(5h)−イル)−6−メチル−4−キナゾリンアミンの結晶形
JP2017506666A5 (OSRAM)
JP2011512396A (ja) 新規な多形およびその調製方法
JP2013538849A5 (OSRAM)
JP2009542787A5 (OSRAM)
JP2018520147A5 (OSRAM)
JP2019527724A5 (OSRAM)
CN114746412A (zh) Kd-025的新晶型及其制备方法